GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Abcellera Biologics ABCL · USD

Health Care · US listing · 🇺🇸 United States

Compare

12.50

+5.22%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Abcellera Biologics and similar listings

Same market and sector, closest in size

Name Last closeMarket valueP/ENet marginYield Change
Abcellera Biologics ABCL 12.50$3.74bn—-194.9%— +5.22%
Uniqure QURE 22.79$1.31bn—-1236.0%— +5.02%
Pacira Biosciences PCRX 36.46$1.64bn233.11.0%— +0.08%
Phathom Pharmaceuticals PHAT 5.33$415.3m—-126.3%— +1.52%
Xeris Biopharma Holdings XERS 15.86$2.74bn3261.50.2%— +4.34%
Astrana Health ASTH 33.77$1.69bn82.70.7%— -2.12%
BioLife Solutions BLFS ———-12.6%— —
GH Research GHRS 19.26$1.19bn——— +3.49%
Fortrea Holdings FTRE 22.24$2.05bn—-36.2%— +1.28%

Closes are in the currency each stock trades in. Blank figures mean we hold no company data for that listing yet.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.